DIBIASE MARY (Chief Operating Officer) sold 17.9% of their position (67.69K shares) of X4 PHARMACEUTICALS, INC on the open market
Open‑market sale worth $49.4K — a significant reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 11/3/2023ACC: 0001628280-23-036757
Officer· Chief Operating Officer
Since Sep 2021
-67.69K
Net shares
Net seller
$49.4K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
67.69K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−67.69K
Price / share
$0.73
Trade value
$49.42K
% of position
17.9%
11/1/2023
378.54K→310.84K
Total
Net shares
−67.69K
Net value
-$49.42K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 11/1/2023 | S · Sale | −67.69K | $0.73 | $49.42K | 17.9% | 378.54K | 310.84K |
| Total | −67.69K | -$49.42K | ||||||
Derivative Transactions0
No derivative transactions reported